QT
KALV

Quantbot Technologies’s KalVista Pharmaceuticals KALV Stock Holding History

Quantbot Technologies’s Portfolio KALV Stock Details KALV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,200
Closed -$30.8K – 1789
2023
Q3 		$30.8K Buy
+3,200
New +$32.7K ﹤0.01% 1313
2022
Q3 		– Sell
-3,500
Closed -$34K – 1836
2022
Q2 		$34K Buy
+3,500
New +$38.6K ﹤0.01% 1376
2022
Q1 		– Sell
-2,200
Closed -$29K – 1846
2021
Q4 		$29K Buy
+2,200
New +$35K ﹤0.01% 1164

Other funds holding KALV

VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Quantbot Technologies's KALV Position: Q4 2023 in Review

Quantbot Technologies sold out of KalVista Pharmaceuticals (KALV) in Q4 2023, closing a stake of 3,200 shares — an estimated $30.8K sold.

Quantbot Technologies first reported a position in KALV in Q4 2021 and held it in 3 quarters. The position peaked at $34K in Q2 2022. 93 funds tracked by Wall St. Rank hold KALV as of Q4 2023.

  • Quantbot Technologies reported no remaining KalVista Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Quantbot Technologies sold 3,200 KalVista Pharmaceuticals shares in Q4 2023, an estimated $30.8K.
  • Quantbot Technologies first reported a position in KalVista Pharmaceuticals in Q4 2021 and held it in 3 quarters.
  • Quantbot Technologies's KalVista Pharmaceuticals position peaked at $34K in Q2 2022.
  • 93 funds tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q4 2023.

Based on Quantbot Technologies's 13F filing for Q4 2023, filed 14 Feb 2024.